BAM
MIRM icon

Bosun Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Bosun Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,530
Closed -$485K – 141
2025
Q2 		$485K Sell
9,530
-596
-6% -$26.5K 0.14% 135
2025
Q1 		$456K Sell
10,126
-287
-3% -$13.5K 0.2% 127
2024
Q4 		$431K Buy
10,413
+3,256
+45% +$136K 0.19% 135
2024
Q3 		$279K Buy
+7,157
New +$285K 0.13% 157

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Bosun Asset Management's MIRM Position: Q3 2025 in Review

Bosun Asset Management sold out of Mirum Pharmaceuticals (MIRM) in Q3 2025, closing a stake of 9,530 shares — an estimated $485K sold.

Bosun Asset Management first reported a position in MIRM in Q3 2024 and held it in 4 quarters. The position peaked at $485K in Q2 2025. 272 funds tracked by Wall St. Rank hold MIRM as of Q3 2025.

  • Bosun Asset Management reported no remaining Mirum Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Bosun Asset Management sold 9,530 Mirum Pharmaceuticals shares in Q3 2025, an estimated $485K.
  • Bosun Asset Management first reported a position in Mirum Pharmaceuticals in Q3 2024 and held it in 4 quarters.
  • Bosun Asset Management's Mirum Pharmaceuticals position peaked at $485K in Q2 2025.
  • 272 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2025.

Based on Bosun Asset Management's 13F filing for Q3 2025, filed 10 Nov 2025.